Vosaroxin for relapsed AML: Updates from VALOR
5 Dec 2016
Vosaroxin for relapsed AML: Updates from VALOR
Venetoclax plus cytarabine in elderly AML patients
Subgroup analysis of elderly high risk AML patients receiving CPX-351
Distress among older cancer patients
The successes of SIOG and geriatric patient advocacy
Geriatric assessment: next big challenges
Exercise, neurodegeneration and prostate cancer
Supportive and palliative care: Exercise for prostate cancer patients
GI and gynaecological tumours in the elderly
Highlights of the SIOG posterwalk
What are the successes of SIOG?
Quality of life in geriatric population